Papillary/Follicular Thyroid Cancer - A Primer with Bryan McIver, M.B., Ph.D., Mayo Clinic, Rochester, MN.
Papillary/Follicular Thyroid Cancer - Persistent Diseasewith Steven I. Sherman, M.D., University of Texas M.D.
Anderson Cancer Center
, Houston, TX.
Speaker: Bryan McIver, M.B., Ph.D., Mayo Clinic, Rochester, MN; ThyCa Medical Advisor
Speaker: Bryan McIver, M.B., Ph.D.
Bryan McIver, M.B., Ph.D., F.R.C.P., Endocrinologist, is with the Thyroid Group within the Division of Endocrinology at Mayo Clinic in Rochester, Minnesota; this group has more than 40 full-time endocrine specialists.
As a consultant in endocrinology, metabolism and nutrition, he has extensive experience treating patients with diseases of the thyroid, specifically those faced with aggressive cancers such as anaplastic thyroid cancer and other advanced thyroid cancers.
also runs a research lab, working on thyroid cancer genetics and on new treatments for patients with thyroid cancer.
Dr. McIver has received numerous awards and honors, including the Endocrine Society Mentor Award for Outstanding Research.
He graduated Summa Cum Laude in Medical Sciences from the University of Edinburgh in Scotland, received his Ph.D. in Physiology and Biophysics from the University of Vermont; and his M.B. Ch.B. Faculty of Medicine at the University of Edinburgh.
He is a member of the American Thyroid Association's Thyroid Cancer Guidelines Development Group.
He is a member of ThyCa's Medical Advisory Council.